Coronary revascularization and use of hemodynamic support in acute coronary syndromes

Area of Science:

• Cardiology
• Interventional Cardiology

Background:

• Cardiogenic shock complicates up to 10% of acute myocardial infarction (AMI) cases, associated with significant mortality.
• Early invasive strategies are standard for AMI with cardiogenic shock.

Purpose of the Study:

• To review current therapeutic approaches for cardiogenic shock complicating AMI.
• To discuss the evidence supporting culprit-only versus multivessel revascularization.
• To evaluate the role of mechanical circulatory support and intra-aortic balloon pumps.

Main Methods:

• Review of clinical trial data, including the CULPRIT-SHOCK trial.
• Analysis of observational studies on mechanical circulatory support.
• Synthesis of evidence regarding revascularization strategies in AMI.

Main Results:

• The CULPRIT-SHOCK trial demonstrated a preference for culprit-only revascularization in acute myocardial infarction complicated by cardiogenic shock.
• Routine use of intra-aortic balloon pump (IABP) is not recommended.
• Multivessel revascularization may improve outcomes in specific patient groups with uncomplicated AMI and non-critical non-culprit lesions.

Conclusions:

• Culprit-only revascularization is the recommended strategy for acute myocardial infarction with cardiogenic shock.
• Mechanical circulatory support use is increasing, but evidence is limited.
• Multivessel revascularization warrants consideration in selected uncomplicated AMI patients.